Your browser doesn't support javascript.
loading
Impact of asparaginase discontinuation on outcomes of children with acute lymphoblastic leukaemia receiving the Japan Association of Childhood Leukaemia Study ALL-02 protocol.
Ishida, Hisashi; Imamura, Toshihiko; Tatebe, Yasuhisa; Ishihara, Takashi; Sakaguchi, Kimiyoshi; Suenobu, Souichi; Sato, Atsushi; Hashii, Yoshiko; Deguchi, Takao; Takahashi, Yoshihiro; Hasegawa, Daiichiro; Miyamura, Takako; Iguchi, Akihiro; Kato, Koji; Saito-Moriya, Akiko; Hara, Junichi; Horibe, Keizo.
Afiliação
  • Ishida H; Department of Pediatrics, Okayama University Hospital, Okayama, Japan.
  • Imamura T; Department of Pediatrics, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
  • Tatebe Y; Department of Pharmacy, Okayama University Hospital, Okayama, Japan.
  • Ishihara T; Department of Pediatrics, Nara Medical University, Kashihara, Japan.
  • Sakaguchi K; Department of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Suenobu S; Division of General Pediatrics and Emergency Medicine, Oita University Faculty of Medicine, Yufu, Japan.
  • Sato A; Department of Hematology/Oncology, Miyagi Children's Hospital, Sendai, Japan.
  • Hashii Y; Department of Pediatrics, Osaka University Graduate School of Medicine, Suita, Japan.
  • Deguchi T; Department of Pediatrics, Mie University, Tsu, Japan.
  • Takahashi Y; Department of Pediatrics, Aomori Prefectural Central Hospital, Aomori, Japan.
  • Hasegawa D; Department of Hematology/Oncology, Hyogo Prefectural Kobe Children's Hospital, Kobe, Japan.
  • Miyamura T; Department of Pediatrics, Osaka University Graduate School of Medicine, Suita, Japan.
  • Iguchi A; Department of Pediatrics, Hokkaido University Hospital, Sapporo, Japan.
  • Kato K; Department of Hematology Oncology, Children's Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
  • Saito-Moriya A; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Hara J; Department of Pediatric Hematology/Oncology, Osaka City General Hospital, Osaka, Japan.
  • Horibe K; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
Br J Haematol ; 201(6): 1200-1208, 2023 06.
Article em En | MEDLINE | ID: mdl-36891758
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras / Hipersensibilidade / Antineoplásicos Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans / Infant País como assunto: Asia Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras / Hipersensibilidade / Antineoplásicos Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans / Infant País como assunto: Asia Idioma: En Ano de publicação: 2023 Tipo de documento: Article